- Home
- NXPLW vs TSI Comparison
NXPLW vs TSI Comparison
Compare NXPLW & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- TSI
- Stock Information
- Founded
- NXPLW N/A
- TSI 1987
- Country
- NXPLW United States
- TSI United States
- Employees
- NXPLW 166
- TSI N/A
- Industry
- NXPLW Telecommunications Equipment
- TSI Investment Managers
- Sector
- NXPLW Telecommunications
- TSI Finance
- Exchange
- NXPLW Nasdaq
- TSI Nasdaq
- Market Cap
- NXPLW N/A
- TSI N/A
- IPO Year
- NXPLW N/A
- TSI N/A
- Fundamental
- Price
- NXPLW N/A
- TSI $4.83
- Analyst Decision
- NXPLW
- TSI
- Analyst Count
- NXPLW 0
- TSI 0
- Target Price
- NXPLW N/A
- TSI N/A
- AVG Volume (30 Days)
- NXPLW 6.4K
- TSI 106.8K
- Earning Date
- NXPLW 03-31-2025
- TSI 01-01-0001
- Dividend Yield
- NXPLW N/A
- TSI 7.46%
- EPS Growth
- NXPLW N/A
- TSI N/A
- EPS
- NXPLW N/A
- TSI N/A
- Revenue
- NXPLW $66,482,000.00
- TSI N/A
- Revenue This Year
- NXPLW N/A
- TSI N/A
- Revenue Next Year
- NXPLW N/A
- TSI N/A
- P/E Ratio
- NXPLW N/A
- TSI N/A
- Revenue Growth
- NXPLW 179.89
- TSI N/A
- 52 Week Low
- NXPLW $0.25
- TSI $4.48
- 52 Week High
- NXPLW $0.26
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- TSI 47.57
- Support Level
- NXPLW N/A
- TSI $4.71
- Resistance Level
- NXPLW N/A
- TSI $4.95
- Average True Range (ATR)
- NXPLW 0.00
- TSI 0.10
- MACD
- NXPLW 0.00
- TSI -0.00
- Stochastic Oscillator
- NXPLW 0.00
- TSI 64.71
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.